These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6444543

  • 1. On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune-deprived mice.
    Houghton JA, Houghton PJ.
    Cancer; 1980 Mar 15; 45(5 Suppl):1159-67. PubMed ID: 6444543
    [Abstract] [Full Text] [Related]

  • 2. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
    Houghton JA, Maroda SJ, Phillips JO, Houghton PJ.
    Cancer Res; 1981 Jan 15; 41(1):144-9. PubMed ID: 7448754
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S, Cadman E.
    Cancer Res; 1982 Sep 15; 42(9):3550-6. PubMed ID: 6213294
    [Abstract] [Full Text] [Related]

  • 5. Relationship between 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas.
    Houghton JA, Weiss KD, Williams LG, Torrance PM, Houghton PJ.
    Biochem Pharmacol; 1986 Apr 15; 35(8):1351-8. PubMed ID: 3008760
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor 5-fluorodeoxyuridylate concentration as a determinant of 5-fluorouracil response.
    Ardalan B, Buscaglia MD, Schein PS.
    Biochem Pharmacol; 1978 Apr 15; 27(16):2009-13. PubMed ID: 718724
    [No Abstract] [Full Text] [Related]

  • 14. In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.
    Sugimoto Y, Ohe Y, Nishio K, Ohmori T, Fujiwara Y, Saijo N.
    Cancer Chemother Pharmacol; 1992 Apr 15; 30(6):417-22. PubMed ID: 1327567
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
    Takimoto CH, Tan YY, Cadman EC, Armstrong RD.
    Biochem Pharmacol; 1987 Oct 01; 36(19):3243-8. PubMed ID: 2444230
    [Abstract] [Full Text] [Related]

  • 17. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
    Iigo M, Nishikata K, Hoshi A.
    Jpn J Cancer Res; 1992 Apr 01; 83(4):392-6. PubMed ID: 1387127
    [Abstract] [Full Text] [Related]

  • 18. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
    Takimoto CH, Cadman EC, Armstrong RD.
    Mol Pharmacol; 1986 Jun 01; 29(6):637-42. PubMed ID: 2940459
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma.
    Berne MH, Gustavsson BG, Almersjö O, Spears PC, Frösing R.
    Cancer Chemother Pharmacol; 1986 Jun 01; 16(3):237-42. PubMed ID: 3698165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.